Article
AP ‐1 is involved in ICOS gene expression downstream of TCR / CD 28 and cytokine receptor signaling
14 May 2012
Abstract excerpt
It has been proposed that sustained ICOS expression in chronic inflammatory immune conditions, such as autoimmunity and allergy, contributes to symptom exacerbation. Therefore modulation of ICOS gene expression could be a potential therapeutic strategy for such immune diseases. However, the precise molecular mechanisms controlling ICOS gene expression remain poorly understood. In this study, we explored...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
